Therapeutics that modulate mast cell activity

Allegria Therapeutics AG

Incorporated

22.12.2023

Headquarters

Basel

Support

Allegria Therapeutics is a Basel-based biopharma startup established in 2023 with a commitment to build a differentiated portfolio of therapeutic approaches around biological targets that modulate mast cells as drivers of allergy and inflammatory disease. We focus our efforts on sustainable innovation to address significant unmet medical need and drive long-term growth.